Making progress: preserving beta cells in type 1 diabetes.
about
Diabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapy.Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T PTPN22 allelic variant: implications in the disease pathogenesisTransient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes.Immunotherapy in type 1 diabetes: a shorter but more winding road?Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.
P2860
Making progress: preserving beta cells in type 1 diabetes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Making progress: preserving beta cells in type 1 diabetes.
@en
Making progress: preserving beta cells in type 1 diabetes.
@nl
type
label
Making progress: preserving beta cells in type 1 diabetes.
@en
Making progress: preserving beta cells in type 1 diabetes.
@nl
prefLabel
Making progress: preserving beta cells in type 1 diabetes.
@en
Making progress: preserving beta cells in type 1 diabetes.
@nl
P2093
P2860
P1476
Making progress: preserving beta cells in type 1 diabetes.
@en
P2093
Carla J Greenbaum
Mary Pat Gallagher
Robin S Goland
P2860
P304
P356
10.1111/J.1749-6632.2011.06321.X
P407
P577
2011-12-01T00:00:00Z